weight loss drug news today glp-1 Medications for Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness GLP-1 Overdoses Are Rising as

The study was published in Investigative Ophthalmology and Visual Science in June 2020

Priority Applications (9) Applications Claiming Priority (1) Related Child Applications (1) Publications (2) Family ID=45879041 Family Applications (2) Family Applications After (1) Country Status (8) Cited By (1) Families Citing this family (6) Citations (1) Family Cites Families (35) 2011 2011-03-25 US US13/072,277 patent/US8609618B2/en active Active 2012 2012-03-08 KR KR1020127027281A patent/KR101445182B1/en not_active Expired - Fee Related 2012-03-08 AU AU2012238087A patent/AU2012238087B2/en active Active 2012-03-08 CN CN2012800013636A patent/CN103327958A/en active Pending 2012-03-08 JP JP2013515592A patent/JP5843853B2/en not_active Expired - Fee Related 2012-03-08 EP EP12710614A patent/EP2547316A2/en not_active Withdrawn 2012-03-08 CA CA2795557A patent/CA2795557C/en active Active 2012-03-08 WO PCT/US2012/028234 patent/WO2012134758A2/en not_active Ceased 2013 2013-10-23 US US14/061,450 patent/US9023801B2/en active Active

While the two are related, they arent the same

Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial